Gritstone bio and Genevant Sciences Announce Option and License Agreement Posted on 15th August 202315th August 2023
Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency Posted on 7th March 2023
Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against Moderna Posted on 28th February 2022
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases Posted on 23rd August 2021
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis Posted on 15th March 202112th March 2021
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine Posted on 20th January 202120th January 2021
Sarepta Therapeutics and Genevant Sciences to Collaborate for LNP-Based Gene Editing Therapeutics Posted on 13th January 202120th January 2021
